Healthcare companies listed on the Nigerian Exchange closed the last trading day of 2025 with a cumulative market capitalization of N466.73 billion.
This is an impressive 220.9% increase from their combined N145.4 billion in 2024, showing strong growth in value on the exchange.
Collectively, these companies accounted for 0.47% of the total Nigerian Exchange market, which, as tracked by the All-Share Index, was valued at N99.38 trillion.
The surge in value was fueled by the exceptional performance of these companies, and in 2025, four pharmaceutical firms delivered returns exceeding 100%, closing the year firmly in the green.
One major reason for this strong performance seems to be higher sales of pharmaceutical products, which helped companies that reported nine-month or full-year results post healthier profits in 2025.
Below are the largest health companies on the NGX, covering pharmaceuticals and healthcare services, based on their market capitalization on the last trading day of 2025.
Mecure Industries Plc holds the top spot with a market capitalization of N260.8 billion at the end of 2025, up from N55.6 billion at the close of 2024. The increase in market value was driven by strong share price gains on the NGX.
In 2025, the company’s shares surged 369%, rising from around N13 to N65.20, with much of the rally occurring in December, when the stock jumped 135.4%.
- The performance was likely supported by robust financials and news of a N10 billion commercial paper launch in December.
In its nine-month financials, revenue nearly doubled, growing 98.6% year-on-year to N60.01 billion, while pre-tax profit climbed 186% to N6.37 billion from N2.23 billion.
Momentum has continued into early 2026, pushing the market cap to N416 billion and the share price to N104 — a remarkable start to the year.
